Choreo LLC trimmed its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 4.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund
DNB Asset Management AS lowered its stake in Merck and Co., Inc. (NYSE: MRK) by 0.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC)
Guru Stock PicksMS Global Franchise Portfolio has made the following transactions:Reduce in MSCI by 17.11%Sold out in FDSAdd in LSE: EXPN by 13.74%New position i
A giant in the healthcare space, Merck ( NYSE:MRK) shares are up 13.5% year-to-date and trading near $119.47, yet retail sentiment on Reddit has slipped from a bullish 63 over the past quarter to a ne
Shifting from higher-risk assets to consistent income sources is a natural progression for retirees.
MENLO PARK, Calif.--(BUSINESS WIRE)--Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has entered into a clinical trial collaboration and supply agreement with Mer
Stock News Nvidia posts record quarter, upbeat outlook: Nvidia (NVDA) reported Q4 revenue of $68.13B with data center sales at $62.3B (91% of total) and guided
Merck & Co. (MRK) is upgraded to buy, driven by improving dividend cushion ratio (DCR) and robust FQ4 2025 earnings recovery. MRK's dividend safety strengthens, with a projected DCR of 2.57x for 2026,
Exploring the Fourth Quarter 2025 N-PORT Filing Bill Nygren (Trades, Portfolio) recently submitted the N-PORT filing for the fourth quarter of 2025, providing
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today t
Merck's two-drug HIV regimen matched Gilead's blockbuster Biktarvy in Phase 3 trials and is under FDA review as the company prepares for Keytruda's patent cliff.
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck Announces Late-Breaking Data from Three Phase 3 Trials Evaluating Doravirine/Islatravir (DOR/ISL), a Once-Daily, Two-Drug Regimen at CROI 2026.
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Compound Planning Inc. lifted its position in Merck and Co., Inc. (NYSE: MRK) by 18.3% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. Th
Dakota Wealth Management decreased its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 12.9% during the third quarter, according to its most recent Form 13F filing with the Securities and Exc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE